Ceftriaxone 1 GM-D5W bags
Ended Awarded Last action
- Contract number
- SPE2DR26F9KD8
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $15,478
Award facts
- Contract value 100% obligated
- $15,478.40 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $15,478.40 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Ceftriaxone 1 GM-D5W bags, with an ultimate completion date of January 8, 2026. This non-set-aside contract represents a single delivery order issued under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical (valued at $999.999 billion through December 2026), which serves as a comprehensive pharmaceutical supply vehicle supporting military healthcare programs globally. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor that supplies a broad portfolio of medications and medical supplies to federal agencies, with the parent company being Cencora, Inc. (doing business as AmerisourceBergen).
Ceftriaxone is a third-generation cephalosporin antibiotic commonly used in military and veteran healthcare settings for treating bacterial infections. The delivery order will be fulfilled at the company's Conshohocken, PA facility. This contract award reflects AmerisourceBergen's ongoing role as a critical vendor within the federal medical supply chain, providing essential pharmaceutical commodities to support Defense Health Agency operations and other government healthcare systems. The competitively awarded delivery order demonstrates the company's continued capability to meet federal procurement requirements for specialized medical products under firm fixed-price terms.
Quick answers
Who was awarded contract SPE2DR26F9KD8?
SPE2DR26F9KD8 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 7, 2026.
How much is contract SPE2DR26F9KD8 worth?
The government has obligated $15,478 on SPE2DR26F9KD8.
Is contract SPE2DR26F9KD8 an order under another contract?
Yes. SPE2DR26F9KD8 is a delivery order under SPE2DR25D2206, an indefinite delivery contract.
Was contract SPE2DR26F9KD8 competed?
The extent of competition for SPE2DR26F9KD8 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award